Experienced in Primitive Neuroectodermal Tumor (PNET)

Dr. Jashmin K. Patel

Oncology | Hematology
St Lukes Clinic-Treasure Valley LLC
190 E Bannock St, 
Boise, ID 
Accepting New Patients
16 Years of Experience
Experienced in Primitive Neuroectodermal Tumor (PNET)
St Lukes Clinic-Treasure Valley LLC
190 E Bannock St, 
Boise, ID 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jashmin Patel is an Oncologist and a Hematologist in Boise, Idaho. Dr. Patel has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Patel is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Oncology
Hematology
Licenses
Internal Medicine in ID
Hospital Affiliations
St Luke's Elmore Medical Center
St Luke's Regional Medical Center
St Luke's Wood River Medical Center
St Luke's Mccall
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

ST LUKES CLINIC-TREASURE VALLEY LLC
190 E Bannock St, Boise, ID 83712
Other Locations
ST LUKES CLINIC-TREASURE VALLEY LLC
610 W Hays St, Boise, ID 83702

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.
A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.
Journal: SpringerPlus
Published: February 27, 2015
Similar Doctors
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Jonathan N. Swerdloff
Oncology | Hematology Oncology | Hematology
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Jonathan N. Swerdloff
Oncology | Hematology Oncology | Hematology

St Lukes Clinic-Treasure Valley LLC

9850 St Lukes Dr, 
Nampa, ID 
 (19.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Swerdloff is an Oncologist and a Hematologist Oncology provider in Nampa, Idaho. Dr. Swerdloff is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Paget Disease of the Breast. Dr. Swerdloff is currently accepting new patients.

Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Norman Zuckerman
Oncology | Hematology | Hematology Oncology
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Norman Zuckerman
Oncology | Hematology | Hematology Oncology

St Lukes Clinic-Treasure Valley LLC

100 E Bannock St, 
Boise, ID 
 (0.1 miles away)
208-381-2983
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Norman Zuckerman is an Oncologist and a Hematologist in Boise, Idaho. Dr. Zuckerman is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Anal Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, and Bone Marrow Aspiration. Dr. Zuckerman is currently accepting new patients.

Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Karl J. Schultheiss
Oncology
Experienced in Primitive Neuroectodermal Tumor (PNET)
Dr. Karl J. Schultheiss
Oncology
1055 N Curtis Rd, 
Boise, ID 
 (3.1 miles away)
208-367-3131
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Karl Schultheiss is an Oncologist in Boise, Idaho. Dr. Schultheiss is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, Chronic B-Cell Leukemia (CBCL), and Astrocytoma. Dr. Schultheiss is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      View All 72 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile